Cha Albert
SEC insider (Form 3/4/5 filer). CIK 0001397906. Chief Executive Officer at Frazier Life Sciences Acquisition Corp. II (FLSC) and 1 other issuer. 1 reported Form 4/5 transaction since Sep 2024; latest on Oct 15, 2026. Located in PALO ALTO, CA.
Companies Cha Albert has filed insider reports for
- Frazier Life Sciences Acquisition Corp. II (FLSC): Director, Officer, 10% Owner, Chief Executive Officer
- Ascendis Pharma A/S (ASND): Director
Cha Albert
CIK: 0001397906
Transaction Breakdown
Open Market Buys (P)1 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
